Y Li1, X Yang, Y Zou, J Li, Q Sun, X Jing, M Yang, S Wang, B Dong. 1. Shuang Wang, MD, The Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University. 37 Guoxuexiang, Chengdu, Sichuan providence, PR. China, 610041; Tel: 86-8542 2329; Fax: 86-28-8542 2321; E-mail: wangs0211@hotmail.com.
Abstract
PURPOSE: Multiple statin-associated muscle symptoms (SAMS) risk factors usually coexist in a given older diabetic patient, but the association between statin use and physical function in older Asian persons with T2MD remains uncertain. The present study therefore sought to provide insight into this uncertainty through a focused assessment of statin-associated outcomes in Chinese diabetic adults. DESIGN: Cross-sectional study. SETTINGS AND PARTICIPANTS: The study included 146 participants with T2MD in the Center of Gerontology and Geriatric, West China Hospital. MEASUREMENTS: The participants received the comprehensive geriatric assessment (CGA). Statin use and other medical data for each patient were determined via assessment of the inpatient hospital information system. Assessments of physical functions included ADLs, IADLs and the Timed "Up and Go" (TUG) test. Multiple regression analyses were then performed in order to determine the relationship between statin utilization and physical function. RESULTS: The average age of these 146 participants (32 women, 21.9%) was 80.00±5.60 years. At enrollment, 78 (53.4%) of the 146 patients were treated with statins. Among the statin users, 48.7% presented with a lack of TUG ability, which was significantly greater than in non-statin users (27.9%). However, the rates of IADL and ADL disabilities did not differ significantly between groups. In a multiple regression analyses, statin use was associated with a three-fold (95% CI 1.06, 9.51) increase in the risk of TUG inability, after adjusted all covariates. CONCLUSIONS: There was a significant association between statin use and TUG inability in older Chinese inpatients with diabetes.
PURPOSE: Multiple statin-associated muscle symptoms (SAMS) risk factors usually coexist in a given older diabeticpatient, but the association between statin use and physical function in older Asian persons with T2MD remains uncertain. The present study therefore sought to provide insight into this uncertainty through a focused assessment of statin-associated outcomes in Chinese diabetic adults. DESIGN: Cross-sectional study. SETTINGS AND PARTICIPANTS: The study included 146 participants with T2MD in the Center of Gerontology and Geriatric, West China Hospital. MEASUREMENTS: The participants received the comprehensive geriatric assessment (CGA). Statin use and other medical data for each patient were determined via assessment of the inpatient hospital information system. Assessments of physical functions included ADLs, IADLs and the Timed "Up and Go" (TUG) test. Multiple regression analyses were then performed in order to determine the relationship between statin utilization and physical function. RESULTS: The average age of these 146 participants (32 women, 21.9%) was 80.00±5.60 years. At enrollment, 78 (53.4%) of the 146 patients were treated with statins. Among the statin users, 48.7% presented with a lack of TUG ability, which was significantly greater than in non-statin users (27.9%). However, the rates of IADL and ADL disabilities did not differ significantly between groups. In a multiple regression analyses, statin use was associated with a three-fold (95% CI 1.06, 9.51) increase in the risk of TUG inability, after adjusted all covariates. CONCLUSIONS: There was a significant association between statin use and TUG inability in older Chinese inpatients with diabetes.
Entities:
Keywords:
Imobility; older Chinese diabetes; physical function; statins use
Authors: Wei-Hsuan Lo-Ciganic; Subashan Perera; Shelly L Gray; Robert M Boudreau; Janice C Zgibor; Elsa S Strotmeyer; Julie M Donohue; Clareann H Bunker; Anne B Newman; Eleanor M Simonsick; Douglas C Bauer; Suzanne Satterfield; Paolo Caserotti; Tamara Harris; Ronald I Shorr; Joseph T Hanlon Journal: J Am Geriatr Soc Date: 2014-12-23 Impact factor: 5.562
Authors: Laurette van Boheemen; Susan E Tett; Evelien Sohl; Jacqueline G Hugtenburg; Natasja M van Schoor; G M E E Peeters Journal: Drugs Aging Date: 2016-06 Impact factor: 3.923
Authors: David S H Lee; Sheila Markwardt; Leah Goeres; Christine G Lee; Elizabeth Eckstrom; Craig Williams; Rongwei Fu; Eric Orwoll; Peggy M Cawthon; Marcia L Stefanick; Dawn Mackey; Douglas C Bauer; Carrie M Nielson Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Shelly L Gray; Aaron K Aragaki; Michael J LaMonte; Barbara B Cochrane; Charles Kooperberg; Jennifer G Robinson; Nancy F Woods; Andrea Z LaCroix Journal: J Am Geriatr Soc Date: 2012-11-23 Impact factor: 5.562
Authors: Erik S Stroes; Paul D Thompson; Alberto Corsini; Georgirene D Vladutiu; Frederick J Raal; Kausik K Ray; Michael Roden; Evan Stein; Lale Tokgözoğlu; Børge G Nordestgaard; Eric Bruckert; Guy De Backer; Ronald M Krauss; Ulrich Laufs; Raul D Santos; Robert A Hegele; G Kees Hovingh; Lawrence A Leiter; Francois Mach; Winfried März; Connie B Newman; Olov Wiklund; Terry A Jacobson; Alberico L Catapano; M John Chapman; Henry N Ginsberg Journal: Eur Heart J Date: 2015-02-18 Impact factor: 29.983
Authors: Miles D Witham; Holly E Syddall; Elaine Dennison; Cyrus Cooper; Marion E T McMurdo; Avan Aihie Sayer Journal: Age Ageing Date: 2014-02-11 Impact factor: 10.668